IVVD: Next-gen monoclonal antibody aims to redefine COVID-19 prevention with scalable, flexible dosing
The company is advancing a next-generation monoclonal antibody for COVID-19 prevention, with pivotal trial data expected soon and regulatory strategies under consideration. Commercial efforts focus on scalable, consumer-friendly products, aiming to transform infectious disease prevention and expand…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.